SHAREHOLDERS' EQUITY (Details) (USD $)	0 Months Ended		12 Months Ended			0 Months Ended				12 Months Ended						0 Months Ended	12 Months Ended				0 Months Ended	1 Months Ended	12 Months Ended	24 Months Ended		0 Months Ended		12 Months Ended
	Jul. 02, 2013	Feb. 02, 2012	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011	Jul. 02, 2013 Common Stock	May 16, 2013 Common Stock	Dec. 30, 2010 Common Stock	Nov. 03, 2010 Common Stock item	Jun. 30, 2013 Common Stock		Jun. 30, 2012 Common Stock		Jun. 30, 2011 Common Stock		Dec. 30, 2010 Warrant issued to two former officers	Jun. 30, 2011 Warrant issued to YA Global	Jun. 30, 2011 Warrant issued to YA Global Common Stock	Jun. 30, 2011 Warrant issued to prior executive	Jun. 30, 2011 Warrant issued to prior executive Common Stock	Dec. 30, 2010 Series A Preferred Stock item	Jan. 31, 2000 Series A Preferred Stock	Jun. 30, 2013 Series A Preferred Stock	Jun. 30, 2001 Series A Preferred Stock	Jun. 30, 2010 Series A Preferred Stock	Nov. 03, 2010 Private Placement Common Stock	Mar. 25, 2011 Public offering Common Stock	Jun. 30, 2012 Minimum	Jun. 30, 2011 Minimum	Jun. 30, 2012 Maximum	Jun. 30, 2011 Maximum
Common stock issuances
Preferred stock, shares issued			0	0																		3,000
Proceeds from issuance of preferred stock																						$ 2,604,190
Stated value (in dollars per share)																						$ 1,000
Par value (in dollars per share)			$ 0.001	$ 0.001																		$ 0.001
Dividend rate (as a percent)																						4.00%
Number of shares converted to common stock																								1,055
Number of shares outstanding			0	0																					1,945
Trading price of common stock when purchased (in dollars per share)																						$ 5.25
Conversion price as percentage of current 5-day trading average																						80.00%
Number of trading days used to calculate trading average																						5 days
Shares of common stock that would have been issued upon conversion																							607,750
Reverse stock split	0.125					0.125
Cancellation of warrants , number of former officers																					2
Warrants cancelled (number of warrants)																100,000
Exercise price of warrants (in dollars per share)																$ 32.00
Common stock surrendered (in shares)								938
Accrued dividend payable eliminated																					372,000
Options exercised (in shares)			95,000	100,625	107,327					95,000	[1]	100,625	[1]	107,327	[1]
Exercised (in dollars per share)			$ 3.92																									$ 2.48	$ 1.92	$ 16.00	$ 16.00
Total gross proceeds from options			372,000	670,000	906,000
Warrants exercised (in shares)			0
Number of shares issued to a former employee as part of a severance agreement							84,375			84,375	[1]
Fair value of shares issued to a former employee as part of a severance agreement							400,000
Period during which sale of shares issued for severance is restricted							6 months
Number of shares issued under the severance agreement eligible for sale after the first 6 months							37,500
Number of remaining shares issued under the severance agreement eligible for sale after 12 months from the issuance date							46,875
Period from the issuance date after which remaining stock issued under the severance agreement is eligible for sale							12 months
Number of shares of common stock sold		1,250,000
Number of shares that can be purchased upon exercise of warrants		1,250,000	400,000	1,700,000	500,000
Net proceeds from offerings		28,162,000		28,162,000	165,999,000
Exercise price of warrants (in dollars per share)		$ 28.00	$ 10.40	$ 23.52	$ 10.08																								$ 7.84		$ 12.64
Number of shares issued upon exercise of warrants on cashless basis, classified as derivative				42,526										48,106	[1]			48,106		21,964
Number of warrants exercised on cashless basis				53,750													87,778
Number of institutional funds agreed to purchase common stock									2
Number of shares issued for cash												1,250,000	[1]	5,468,750	[1]											1,875,000	3,125,000
Purchase price of common stock (in dollars per share)																										$ 16.00	$ 40.00
Proceeds from issuance of common stock, net of offering costs																										29,900,000	136,100,000
Purchase price of common stock, net of underwriting discount but before deducting transaction expenses (in dollars per share)																											$ 38.00
Duration of exercise period for option granted to underwriter																											45 days
Option granted to underwriter to purchase additional shares (in shares)																											468,750
Number of shares issued to underwriter upon exercise of options																											468,750
Warrants exercised (number of warrants)					770,527														30,000
Proceeds from exercise of warrants					$ 7,709,000
Shares of stock issued under settlement agreement or upon conversion								29,930

[1] All share amounts and computations using such amounts have been retroactively adjusted to reflect the July 1, 2013 1-for-8 reverse stock split.